Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Germany Herbal Medicine Market

ID: MRFR/HC/42320-HCR
200 Pages
Satyendra Maurya
Last Updated: April 24, 2026
Germany Herbal Medicine Market Research Report By Herbal Medicine Form Outlook (Extracts, Powders, Capsules Tablets, Syrups), By Herbal Medicine Distribution Channel Outlook (Hospital Retail Pharmacies, E-Commerce), By Herbal Medicine Category Outlook (Herbal Pharmaceuticals, Herbal Functional Foods, Herbal Beauty Products, Herbal Dietary Supplements), By Herbal Medicine Type of Medicinal Plants (Marrubium Vulgare, Vaccinium Macrocarpon, Echinacea, Curcuma Longa, Camellia Sinensis, Actaea Racemose, Aloe Vera, Zingiber Officinale, Cocos Nucifera, Cinnamomum Spp, Allium Sativum) and By Herbal Medicine Source Outlook (Leaves, Root Barks, Whole Plants, Fruits) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Chemicals and Materials, BY Form (USD Billion)
      1. 4.1.1 Extracts
      2. 4.1.2 Powders
      3. 4.1.3 Capsules & Tablets
      4. 4.1.4 Syrups
    2. 4.2 Chemicals and Materials, BY Distribution Channel (USD Billion)
      1. 4.2.1 Hospital & Retail Pharmacies
      2. 4.2.2 E-Commerce
    3. 4.3 Chemicals and Materials, BY Category (USD Billion)
      1. 4.3.1 Herbal Pharmaceuticals
      2. 4.3.2 Herbal Functional Foods
      3. 4.3.3 Herbal Beauty Products
      4. 4.3.4 Herbal Dietary Supplements
    4. 4.4 Chemicals and Materials, BY Type of Medicinal Plants (USD Billion)
      1. 4.4.1 Marrubium Vulgare
      2. 4.4.2 Vaccinium Macrocarpon
      3. 4.4.3 Echinacea
      4. 4.4.4 Curcuma Longa
      5. 4.4.5 Camellia Sinensis
      6. 4.4.6 Actaea Racemose
      7. 4.4.7 Aloe Vera
      8. 4.4.8 Zingiber Officinale
      9. 4.4.9 Cocos Nucifera
      10. 4.4.10 Cinnamomum Spp
      11. 4.4.11 Allium Sativum
    5. 4.5 Chemicals and Materials, BY Source (USD Billion)
      1. 4.5.1 Leaves
      2. 4.5.2 Root & Barks
      3. 4.5.3 Whole Plants
      4. 4.5.4 Fruits
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Herbalife (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Nature's Way (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Gaia Herbs (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Schwabe Pharmaceuticals (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Traditional Medicinals (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Himalaya Wellness (IN)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Dabur (IN)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Zandu Pharmaceutical Works (IN)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Bioforce AG (CH)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 GERMANY MARKET ANALYSIS BY FORM
    3. 6.3 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    4. 6.4 GERMANY MARKET ANALYSIS BY CATEGORY
    5. 6.5 GERMANY MARKET ANALYSIS BY TYPE OF MEDICINAL PLANTS
    6. 6.6 GERMANY MARKET ANALYSIS BY SOURCE
    7. 6.7 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF CHEMICALS AND MATERIALS
    10. 6.10 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
    12. 6.12 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
    13. 6.13 CHEMICALS AND MATERIALS, BY FORM, 2024 (% SHARE)
    14. 6.14 CHEMICALS AND MATERIALS, BY FORM, 2024 TO 2035 (USD Billion)
    15. 6.15 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    16. 6.16 CHEMICALS AND MATERIALS, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
    17. 6.17 CHEMICALS AND MATERIALS, BY CATEGORY, 2024 (% SHARE)
    18. 6.18 CHEMICALS AND MATERIALS, BY CATEGORY, 2024 TO 2035 (USD Billion)
    19. 6.19 CHEMICALS AND MATERIALS, BY TYPE OF MEDICINAL PLANTS, 2024 (% SHARE)
    20. 6.20 CHEMICALS AND MATERIALS, BY TYPE OF MEDICINAL PLANTS, 2024 TO 2035 (USD Billion)
    21. 6.21 CHEMICALS AND MATERIALS, BY SOURCE, 2024 (% SHARE)
    22. 6.22 CHEMICALS AND MATERIALS, BY SOURCE, 2024 TO 2035 (USD Billion)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY FORM, 2025-2035 (USD Billion)
      2. 7.2.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
      3. 7.2.3 BY CATEGORY, 2025-2035 (USD Billion)
      4. 7.2.4 BY TYPE OF MEDICINAL PLANTS, 2025-2035 (USD Billion)
      5. 7.2.5 BY SOURCE, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Germany Chemicals and Materials Market Segmentation

Chemicals and Materials By Form (USD Billion, 2025-2035)

  • Extracts
  • Powders
  • Capsules & Tablets
  • Syrups

Chemicals and Materials By Distribution Channel (USD Billion, 2025-2035)

  • Hospital & Retail Pharmacies
  • E-Commerce

Chemicals and Materials By Category (USD Billion, 2025-2035)

  • Herbal Pharmaceuticals
  • Herbal Functional Foods
  • Herbal Beauty Products
  • Herbal Dietary Supplements

Chemicals and Materials By Type of Medicinal Plants (USD Billion, 2025-2035)

  • Marrubium Vulgare
  • Vaccinium Macrocarpon
  • Echinacea
  • Curcuma Longa
  • Camellia Sinensis
  • Actaea Racemose
  • Aloe Vera
  • Zingiber Officinale
  • Cocos Nucifera
  • Cinnamomum Spp
  • Allium Sativum

Chemicals and Materials By Source (USD Billion, 2025-2035)

  • Leaves
  • Root & Barks
  • Whole Plants
  • Fruits